3B), as reported for human fibroblasts, liver extracts, and transfected CHO cells [2, 17, 30]. 3.5 PF-4989216 Immunocytochemical analysis of transfected HEK-293 cells Immunocytochemistry was used to investigate the differences between recombinant wild-type and mutant CBS proteins expressed in HEK-293 cells. the D234N protein showed both distributions. This study demonstrates that this pathogenic mutations generate unstable proteins that are unable (T87N) or partially unable (D234N) to assemble into a functional enzyme, implying that these mutations might be responsible for the homocystinuria phenotype. gene are the most common cause of classical homocystinuria (HCU, MIM# 236200), an autosomal recessive disorder characterized by elevated plasma homocysteine levels (usually 100 M) and clinical manifestations in the ocular, skeletal, vascular and nervous systems. PF-4989216 This disorder has an estimated worldwide frequency of 1 1:344,000, according to data registered by countries which performed neonatal screening [1]. However, this frequency is usually expected to be higher since the techniques currently utilized for homocystinuria screening only detect the most severe cases of the disease [2]. Treatment of homocystinuria is based on methionine intake restriction from the diet and on PF-4989216 vitamin B6 (pyridoxine) supplementation, administration of betaine is also recommended in pyridoxine-nonresponsive patients. Two CBS deficiency-associated homocystinuric phenotypes, pyridoxine-responsive and nonresponsive, have been recognized based on the decrease in plasma homocysteine levels by vitamin B6 treatment [3]. The active form of the human CBS enzyme, the homotetramer, is usually created by 4 subunits of 63 kDa each. Each subunit has a modular business, an N-terminal catalytic domain name that contains the binding sites for the heme group (ligated by C52 and STEP H65), PLP and the substrates; and the C-terminal regulatory domain name, which binds S-adenosylmethionine (SAM), an allosteric activator [4, 5]. An activated form of the enzyme is usually generated upon truncation of the C-terminal regulatory domain name. The producing subunits have a molecular mass of 45 kDa and the truncated enzyme has a four-fold higher turnover number than the full-length enzyme in the absence of SAM [6, 7, 8, 9]. So far, 158 mutations have been explained in the human gene (MIM# 613381). Most are missense mutations (http://cbs.lf1.cuni.cz/index.php), many are located in the catalytic domain name of the protein and are predicted to impair either cofactor or substrate binding or the formation of the quaternary structure of the protein. Mutations within the C-terminal domain name are also capable of affecting the oligomeric state of the enzyme or may impair SAM-dependent regulation [5, 10, 11]. Analysis of mutant CBS proteins has led to some understanding of the biological basis for vitamin B6 responsiveness in homocystinuric patients [12, 13, 14, 15], the role of the heme group in the stability and regulation of the CBS activity [16, 17, 18], the autoinhibitory action of the C-terminal domain PF-4989216 name and the allosteric activation by SAM [8, 12, 16, 19]. These studies have also provided important insights into the biochemical properties of the enzyme and have contributed to the understanding of genotype-phenotype correlations. In this study, we have characterized two mutations, c.260C A (p.T87N) and c.700G A (p.D234N), found in two Venezuelan homocystinuric patients, one responsive, the other nonresponsive to vitamin B6 treatment. This is the first report of the p.T87N mutation, which was found in compound heterozygosity with the p.G85R mutation around the other allele. The p.T87N mutation is located in exon 2 from your gene, and resulted from a C A alteration at nucleotide 260 in the cDNA sequence. The p.D234N mutation has been previously described (http://cbs.lf1.cuni.cz/index.php) [20, 21, 22]; however, its effect on the properties of the CBS protein have not been studied. Both mutations are located in the catalytic domain name of CBS and impact the oligomeric state and enzyme activity. Furthermore, fluorescence microscopy of transfected HEK-293 cells expressing recombinant wild-type and mutant CBS proteins reveal unexpected.
